Vancomycin-resistant enterococci colonization among dialysis patients: A meta-analysis of prevalence, risk factors, and significance

American Journal of Kidney Diseases

Volumn 65, Issue 1, 2015, Pages 88-97

  Zacharioudakis, Ioannis M ^a   Zervou, Fainareti N ^a   Ziakas, Panayiotis D ^a   Rice, Louis B ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Colonization; End stage renal disease (ESRD); Hemodialysis; Meta analysis; Nosocomial infection; Peritoneal dialysis; Renal dialysis; Renal replacement therapy (RRT); Vancomycin resistant enterococci (VRE)

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; ENTEROCOCCAL INFECTION; HEALTHCARE ASSOCIATED INFECTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; LONG TERM CARE; META ANALYSIS; NORTH AMERICAN; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SYSTEMATIC REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION; BACTERIAL COUNT; CROSS INFECTION; ISOLATION AND PURIFICATION; KIDNEY FAILURE, CHRONIC; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; VANCOMYCIN; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84922362342     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.05.016     Document Type: Article

References (74)

1. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16(6): 750-755
2. Marcade G, Micol JB, Jacquier H, et al. Outbreak in a haematology unit involving an unusual strain of glycopeptideresistant Enterococcus faecium carrying both vanA and vanB genes. J Antimicrob Chemother. 2014;69(2):500-505
3. Escaut L, Bouam S, Frank-Soltysiak M, et al. Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): The cost of a failure in the systematic screening. Antimicrob Resist Infect Control. 2013;2(1):18
4. Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009;30(2): 184-186
5. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect Control Hosp Epidemiol. 2003;24(9):690-698
6. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Clin Infect Dis. 2005;41(3):327-333
7. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348(14):1342-1347
8. Weigel LM, Clewell DB, Gill SR, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302(5650):1569-1571
9. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65(suppl 2): 50-54
10. Sample ML, Gravel D, Oxley C, Toye B, Garber G, Ramotar K. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: Control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol. 2002;23(8):468-470
11. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycinresistant enterococci. Lancet. 1996;348(9042):1615-1619
12. Baden LR, Thiemke W, Skolnik A, et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in longterm care patients and the significance of "clearance.". Clin Infect Dis. 2001;33(10):1654-1660
13. Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2002;23(4):207-211
14. Humphreys H, Dolan V, Sexton T, et al. Implications of colonization of vancomycin-resistant enterococci (VRE) in renal dialysis patients. Learning to live with it? J Hosp Infect. 2004;58(1):28-33
15. Brown AR, Amyes SG, Paton R, et al. Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. J Hosp Infect. 1998;40(2):115-124
16. Uttley AH, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 1989;103(1):173-181
17. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States. MMWR Morb Mortal Wkly Rep. 2002;51(26):565-567
18. Collins AJ, Foley RN, Chavers B, et al. US Renal Data System 2013 annual data report. Am J Kidney Dis. 2014; 63(1)(suppl 1):e1-e420
19. D'Agata EM. Antimicrobial use and stewardship programs among dialysis centers. Semin Dial. 2013;26(4):457-464
20. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012
21. Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/ programs/clinical-epidemiology/oxford.asp. Accessed February 10, 2014
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188
23. Fazel S,KhoslaV,DollH,Geddes J.The prevalence ofmental disorders among the homeless in Western countries: systematic review and meta-regression analysis. PLoS Med. 2008;5(12):e225
24. Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-634
26. Freitas MC, Pacheco-Silva A, Barbosa D, et al. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis. 2006;6:133
27. D'Agata EM, Green WK, Schulman G, Li H, Tang YW, Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition. Clin Infect Dis. 2001;32(1):23-29
28. Correia S, Ponce P, Jones-Dias D, Canica M, Igrejas G, Poeta P. Vancomycin-resistant enterococci among haemodialysis patients in Portugal: Prevalence and molecular characterization of resistance, virulence and clonality. Enferm Infecc Microbiol Clin. 2014;32(3):174-176
29. Shaghaghian S, Pourabbas B, Alborzi A, Askarian M, Mardaneh J. Vancomycin-resistant entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006). Iran Red Crescent Med J. 2012;14(10):686-691
30. Kee SY, Park CW, Lee JE, et al. Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis. Jpn J Infect Dis. 2012;65(1): 57-60
31. Pop-Vicas A, Strom J, Stanley K, D'Agata EM. Multidrugresistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol. 2008;3(3):752-758
32. Graham M, Ballard SA, Grabsch EA, Johnson PD, GraysonML. High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother. 2008;52(3): 1195-1197
33. Assadian O, Askarian M, Stadler M, Shaghaghian S. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran. BMC Infect Dis. 2007;7:52
34. Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol. 2007;27(4):352-359
35. Burrell LJ, Grabsch EA, Padiglione AA, Grayson ML. Prevalence of colonisation with vancomycin-resistant enterococci (VRE) among haemodialysis outpatients in Victoria: Implications for screening. Med J Aust. 2005;182(9):492
36. Kalocheretis P, Baimakou E, Zerbala S, et al. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece. J Antimicrob Chemother. 2004;54(6): 1031-1034
37. Barbosa D, Lima L, Silbert S, et al. Evaluation of the prevalence and risk factors for colonization by vancomycinresistant Enterococcus among patients on dialysis. Am J Kidney Dis. 2004;44(2):337-343
38. Tokars JI, Gehr T, Jarvis WR, et al. Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney Int. 2001;60(4):1511-1516
39. Atta MG, Eustace JA, Song X, Perl TM, Scheel PJ Jr. Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients. Kidney Int. 2001;59(2):718-724
40. Descheemaeker P, Ieven M, Chapelle S, et al. Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis. 2000;181(1):235-241
41. von Baum H, Schehl J, Geiss HK, Schaefer F. Prevalence of vancomycin-resistant enterococci among children with endstage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis. 1999;29(4):912-916
42. Dan M, Poch F, Leibson L, Smetana S, Priel I. Rectal colonization with vancomycin-resistant enterococci among highrisk patients in an Israeli hospital. J Hosp Infect. 1999;43(3): 231-238
43. Grayson ML, Grabsch EA, Johnson PD, et al. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust. 1999;171(3):133-136
44. Fishbane S, Cunha BA, Mittal SK, Ruggian J, Shea K, Schoch PE. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use. Infect Control Hosp Epidemiol. 1999;20(7):461-462
45. Ieven M, Vercauteren E, Descheemaeker P, van Laer F, Goossens H. Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptideresistant enterococci among hospitalized patients. J Clin Microbiol. 1999;37(5):1436-1440
46. Korff A, Larson E, Kumar P, Peters S, Jackson D. Vancomycin resistant enterococcus in a hospital-based dialysis unit. ANNA J. 1998;25(4):381-386; quiz 387-388
47. Brady JP, Snyder JW, Hasbargen JA. Vancomycin-resistant enterococcus in end-stage renal disease. Am J Kidney Dis. 1998;32(3):415-418
48. Roghmann MC, Fink JC, Polish L, et al. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. Am J Kidney Dis. 1998;32(2):254-257
49. Low CL, Eisele G, Cerda J, et al. Low prevalence of vancomycin-resistant Enterococcus in dialysis outpatients with a history of vancomycin use. Perit Dial Int. 1996;16(6):651-652
50. Embil JM, Kabani A, Zhanel G, Nicolle LE. Low prevalence of gastrointestinal colonization with antimicrobial-resistant bacteria in high risk units in a Canadian tertiary care centre. Can J Infect Dis. 1996;7(5):307-312
51. Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Meta-analysis of MRSA colonization and risk of infection in dialysis patients [published online ahead of print March 20, 2014]. J Am Soc Nephrol. http://dx.doi.org/10.1681/ASN.2013091028
52. D'Agata EM. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis. 2002;35(10):1212-1218
53. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial. 2003;16(1):30-37
54. D'Agata EM, Horn MA, Webb GF. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis. 2002;185(6):766-773
55. Rice LB. The complex dynamics of antimicrobial activity in the human gastrointestinal tract. Trans Am Clin Climatol Assoc. 2013;124:123-132
56. Bonten MJ, Willems R, Weinstein RA. Vancomycinresistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis. 2001;1(5):314-325
57. Bates J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect. 1997;37(2):89-101
58. van den Bogaard AE, Bruinsma N, Stobberingh EE. The effect of banning avoparcin on VRE carriage in the Netherlands. J Antimicrob Chemother. 2000;46(1):146-148
59. Kempf I, Hellard G, Perrin-Guyomard A, Gicquel- Bruneau M, Sanders P, Leclercq R. Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs. Int J Antimicrob Agents. 2008;32(5):463-464
60. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686-707
61. Martone WJ. Spread of vancomycin-resistant enterococci: Why did it happen in the United States? Infect Control Hosp Epidemiol. 1998;19(8):539-545
62. Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: A meta-analysis of published studies. PLoS One. 2013;8(9):e75658
63. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrugresistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362-386
64. Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D'Agata EM. Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol. 2013;34(4):349-357
65. Currie BP, Lemos-Filho L. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: Potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2004;48(11): 4427-4429
66. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925-1932
67. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med. 2001;135(3):175-183
68. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, BilkerWB, Fishman NO. Changes in the prevalence of vancomycinresistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis. 2003;36(4):440-446
69. Paule SM, Trick WE, Tenover FC, et al. Comparison of PCR assay to culture for surveillance detection of vancomycinresistant enterococci. J Clin Microbiol. 2003;41(10):4805-4807
70. Drews SJ, Johnson G, Gharabaghi F, et al. A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium. J Clin Microbiol. 2006;44(4):1578-1580
71. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycinresistant enterococci. Clin Infect Dis. 2002;34(2):167-172
72. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008
73. Patel PR, Yi SH, Booth S, et al. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report. Am J Kidney Dis. 2013;62(2):322-330
74. Nguyen DB, Lessa FC, Belflower R, et al. Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. Clin Infect Dis. 2013;57(10):1393-1400.